search icon
  • Print
  • ShareThis
  • Text Size


In order to add a post to the discussion forum you need to be an IDSA member. If you are an IDSA member, please login now. Please read our Discussion Forum Guidelines and Terms of Use before joining.

Hepatitis C

Welcome to Hepatitis C Management Discussion Board! The Hepatitis C Management Discussion Board provides Infectious Disease Clinicians a platform to connect with colleagues to exchange information, case studies, complications, and new developments on matters concerning hepatitis C treatment and management. Certain case studies will be developed into clinical vignettes and will be available to Infectious Disease Clinicians for future reference. Please be respectful of all participants and their respective comments. Please read our Terms of Use and Discussion Forum Guidelines.

 

Any diagnostic or therapeutic recommendations and all opinions presented are those of the individual contributor. They do not necessarily represent the views of IDSA. The reader assumes all risks in using this information. The IDSA Hepatitis C Discussion Forum is in full compliance with HIPPA. IDSA bears no responsibility for the accuracy of participant comments and will bear no legal liability for discussion results.

If a participant wishes to post an issue on the IDSA Hepatitis C Discussion Forum, the participant is strongly urged to provide contact information for possible offline discussion via phone or email concerning the posted issue.


RSS Feed Search Category View 
Drug Therapy
  Topics Topic Starter Replies Views Last Post
AbbVie Announces Positive Phase III Results ThomasKim 0 5686 Friday, April 11, 2014 1:52 PM 
AbbVie steps closer to FDA filing as first hep C PhIII delivers promising results tkim@idsociety.org 0 6594 Monday, November 18, 2013 1:45 PM 
AbbVie Submits FDA Application for All Oral HCV Therapy tkim@idsociety.org 0 5733 Tuesday, April 22, 2014 1:52 PM 
Bristol-Myers gains FDA breakthrough track for HCV drug approval tkim@idsociety.org 0 9772 Thursday, April 25, 2013 2:00 PM 
Bristol-Myers Squibb Files for FDA Approval of NS5A Drug Combination tkim@idsociety.org 0 5727 Thursday, April 10, 2014 1:50 PM 
Clinicians Wait for Next Wave of Hepatitis C Antivirals - By: Debra Gordon tkim@idsociety.org 0 8930 Tuesday, June 11, 2013 3:43 PM 
FDA Approved Changes to Incivek (telaprevir) Product Labeling to Include OPTIMIZE Trial Results tkim@idsociety.org 0 6894 Wednesday, October 30, 2013 7:56 AM 
FDA approves Sovaldi for chronic hepatitis C ThomasKim 0 6552 Monday, December 9, 2013 10:21 AM 
FDA Internal Review of Sofosbuvir tkim@idsociety.org 0 6940 Wednesday, October 23, 2013 1:21 PM 
Gilead applies for FDA approval for Sofosbuvir ThomasKim 0 9789 Tuesday, April 9, 2013 1:36 PM 
Gilead gains FDA approval for hep C combo pill ThomasKim 0 1387 Monday, October 13, 2014 12:34 PM 
Gilead Next Generation Combination Pill ThomasKim 0 5865 Monday, March 24, 2014 1:01 PM 
Gilead Passes Two Phase III Test with HCV Pill ThomasKim 0 10033 Monday, February 4, 2013 4:01 PM 
Gilead says payers feel comfortable with the cost of Sovaldi ThomasKim 0 6167 Friday, February 14, 2014 1:06 PM 
Gilead Successfully Completes Fourth Phase III Study tkim 0 9789 Tuesday, February 19, 2013 1:03 PM 
Gilead's Sofosbuvir Gains FDA Panel Approval tkim@idsociety.org 0 6962 Monday, October 28, 2013 1:14 PM 
Indication and Usage of Olysio (simeprevir) for the Treatment of Chronic Hepatitis C ThomasKim 0 6549 Monday, November 25, 2013 2:38 PM 
J&J wins FDA panel blessing for hep C blockbuster hopeful ThomasKim 0 6793 Friday, October 25, 2013 2:32 PM 
J&J, Gilead combo drug therapy clears hep C in 100% of Phase IIa cohort ThomasKim 0 10153 Monday, March 4, 2013 1:00 PM 
J&J, Medivir gain FDA OK for new hep C therapy simeprevir ThomasKim 0 6567 Monday, November 25, 2013 1:08 PM 
Key hep C protein revealed, paving the way for new vaccines tkim@idsociety.org 0 6501 Wednesday, December 4, 2013 7:57 AM 
Merck Unveils Interim Phase II Results tkim@idsociety.org 0 5715 Thursday, April 10, 2014 1:46 PM 
More Drugs Show Promise in Fighting Hepatitis C - HealthDay Article ThomasKim 0 7457 Thursday, August 15, 2013 11:36 AM 
Phase III Results for Gilead Hep C Combo tkim@idsociety.org 0 6451 Wednesday, December 18, 2013 12:51 PM 
Simeprevir Earns Positive Internal Review from FDA ThomasKim 0 6959 Tuesday, October 22, 2013 1:33 PM 
Spurred by pricey Gilead hep C drug, payers cook up new cost-control moves tkim@idsociety.org 0 6343 Monday, January 27, 2014 1:44 PM 
 

| HIVMA | Contact Us

© Copyright IDSA 2014 Infectious Diseases Society of America

Full Site Mobile Site